Welcome!
Dr. Srivastava’s research has been focused on the following two parvoviruses, the non-pathogenic adeno-associated virus (AAV), and a common human pathogen, the parvovirus B19, and the development of recombinant parvovirus vectors in human gene therapy.
Principal Investigator
Arun Srivastava, PhD
Dr. Srivastava is George H. Kitzman Professor of Genetics and Chief of Division of Cellular and Molecular Therapy in the Department of Pediatrics, and Department of Molecular Genetics and Microbiology, and Powell Gene Therapy Center. He also serves as Assistant Director of the University of Florida General Clinical Research Center.
UF Pediatric News
Atsena Therapeutics Receives FDA Designation for Treatment of Severe Congenital Eye Disease Using Gene Therapy
The company was created by ocular gene therapy pioneers Dr. Shannon Boye and Associate Scientist Sanford Boye, who also run the Shannon E. Boye Laboratory in the UF College of Medicine’s Department…
Dr. Neu Receives AAP Neonatology Education Award
Josef Neu, M.D., Professor and Co-Director of the Neonatal-Perinatal Medicine Fellowship Program, was honored with the Avroy Fanaroff Neonatal Education Award at the 2023 American Academy of Pediatrics Annual Meeting due…
Tech Tuesday: A Helpful Virus
In this Tech Tuesday for WCJB TV20, UF Innovate’s Melanie Morón interviews Dr. Arun Srivastava from the University of Florida’s College of Medicine Department of Pediatrics who introduces us to…
Minds and Machines
Addressing autism spectrum disorder.UF neuroscientists are studying autism in new ways, from Padilla-Coreano’s research to that of pediatric neurologist Brandon Zielinski, MD, PhD, who uses MRI to analyze the structure and function of brain…
